Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Health Promot Pract ; 24(5): 993-997, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37440311

RESUMO

A decline in the HIV workforce has led to a crisis of insufficient expertise to manage people with HIV (PWH), roughly a quarter of whom are coinfected with hepatitis C. Task shifting to nonspecialist providers can contribute to solving the HIV workforce shortage problem, but nonspecialist providers require sufficient training and support to acquire and retain the necessary knowledge and skills. Digital tools including mobile applications (apps) and telementoring which utilizes telecommunication technology for education and skill acquisition can be used for professional development. Described is the development and dissemination of a mobile app specifically for providers managing HIV/HCV coinfection in the United States. The app, through provider professional development, facilitates access to curative HCV treatment in PWH, encourages integration of HCV care into primary care and contributes to national goals to eliminate HIV and viral hepatitis by 2030.


Assuntos
Coinfecção , Infecções por HIV , Hepatite C Crônica , Hepatite C , Hepatite Viral Humana , Aplicativos Móveis , Humanos , Estados Unidos , Antivirais/uso terapêutico , Coinfecção/tratamento farmacológico , Hepatite C/prevenção & controle , Hepatite C/tratamento farmacológico , Hepacivirus , Infecções por HIV/prevenção & controle , Infecções por HIV/tratamento farmacológico , Hepatite Viral Humana/tratamento farmacológico , Hepatite C Crônica/tratamento farmacológico
2.
Health Promot Pract ; 24(5): 990-992, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37440327

RESUMO

The treatment and cure of hepatitis C (HCV) in people with HIV is particularly important as progression of their liver disease is quicker compared with those who have HCV monoinfection. Innovative approaches are needed to maximize access to curative HCV treatment. Integration of HCV care into HIV primary care with education and support of nonspecialist providers via telementoring offers a solution to specialist workforce shortages. Using focus group qualitative methodology, health care workers' perspectives regarding this approach, particularly with the Extension for Community Healthcare Outcomes (ECHO) telementoring model, were obtained and are described. Successful integration of HCV care into HIV primary care has demonstrated benefits to patients, including allowing them to remain in their medical home for care. Factors beyond disease that influence their health and wellbeing must also be considered.


Assuntos
Infecções por HIV , Hepatite C , Humanos , Hepatite C/terapia , Hepacivirus , Infecções por HIV/terapia
3.
Health Promot Pract ; 24(5): 982-989, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37440447

RESUMO

The COVID-19 pandemic has resulted in a steep increase in telemedicine implementation and use. Data are lacking on telemedicine use in marginalized and underserved groups including people with HIV (PWH). The Ryan White HIV/AIDS Program (RWHAP) is the largest single provider of HIV care in the United States (U.S.) and the southern part of the country remains the epicenter of the HIV epidemic. This study recruited PWH from RWHAP clinics across South Texas. To ascertain their perspectives on utilizing telemedicine for HIV care during the COVID-19 pandemic, a survey instrument derived from validated instruments was used. Descriptive statistics were used for client characteristics, quality of telemedicine care, and COVID-19 impact. Wilcoxon Rank Sum and Kruskal-Wallis tests were assessed associations of telemedicine care quality and COVID-19 impact between client groups. Among 246 eligible PWH, 122 clients completed the survey with a response rate of 50%. Clients were predominantly Hispanic males. Significant differences in perception of telemedicine care and the impact of COVID-19 by gender, age, language, and race/ethnicity were observed. Older PWHIV used telemedicine more than younger clients (p = .01). English speakers indicated more impact of the COVID-19 pandemic on daily life than Spanish speakers (p = .02). Worry about the pandemic was most evident among non-Hispanic Black and Hispanic PWH (p = .03). Overall, telemedicine was found to be a favorable and acceptable mechanism of HIV care delivery by PWH in a Southern state during the COVID-19 pandemic.


Assuntos
COVID-19 , Infecções por HIV , Telemedicina , Masculino , Humanos , Estados Unidos/epidemiologia , COVID-19/epidemiologia , Infecções por HIV/epidemiologia , Infecções por HIV/terapia , Pandemias , Atenção à Saúde
4.
Health Promot Pract ; 24(5): 973-981, 2023 09.
Artigo em Inglês | MEDLINE | ID: mdl-37440490

RESUMO

Direct-acting antivirals are overwhelmingly effective in curing hepatitis C (HCV). Barriers to HCV treatment exist for those co-infected with both HIV and HCV. Southern states represent the epicenter of the HIV epidemic in the United States. This study assessed HCV knowledge, attitudes, and perceptions in 318 co-infected individuals attending Ryan White HIV/AIDS Program (RWHAP) clinics in three South Texas cities. Two groups were compared, those tested for HCV and aware of their results (Group 1) and those uncertain if they were tested or tested and unaware of their results (Group 2). HCV knowledge was poor overall. Group 1 had a significantly higher mean HCV knowledge score than Group 2 by t-test (48.6 vs. 38.8; p < .01), but not by multivariable linear regression (p=.14). Factors predictive of greater HCV knowledge included self-identification as lesbian, gay, bisexual, transgender, queer and post high school educational attainment. Significantly more in Group 1 compared with Group 2 agreed that HCV medications would keep a person healthier for longer. Spanish speakers were more likely to disagree with a statement that people of color receive the same treatment for hepatitis C as white people. Study limitations identified include poor generalizability to people with HIV (PWH) receiving care in non-RWHAP settings and rural communities. Despite limitations, this study augments the paucity of information about knowledge, attitudes, and perceptions of HCV in PWH and can inform interventions to combat barriers to HCV treatment and to maximize opportunities for HCV screening, diagnosis, and linkage to curative care.


Assuntos
Infecções por HIV , Hepatite C Crônica , Hepatite C , Feminino , Humanos , Estados Unidos , Texas/epidemiologia , Antivirais , Conhecimentos, Atitudes e Prática em Saúde , Hepatite C/tratamento farmacológico , Hepatite C/epidemiologia , Hepacivirus , Infecções por HIV/diagnóstico
5.
J Med Educ Curric Dev ; 8: 23821205211041178, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34621993

RESUMO

BACKGROUND: People with human immunodeficiency virus (PWHIV) who have hepatitis C virus (HCV) coinfection are at a higher risk of progression of liver disease than the general population. Direct acting antivirals provide a therapeutic option for HCV cure, however access to HCV specific care for PWHIV can be challenging. A paucity of specialist providers is a barrier to this care. OBJECTIVES: This study aims to assess knowledge gained about HIV/HCV coinfection among health care providers. METHODS: AIDS Education Training Centers (AETC) have developed a modular national HIV/HCV coinfection curriculum consisting of a free selfdirected online curriculum to educate health care providers, including nonspecialist providers, involved in the care of PWHIV on HCV care and management. The effectiveness of this curriculum was evaluated with pre and post module assessment completion by learners compared with a paired t-test. RESULTS: 716 people received links to the curriculum and 277 modules were completed by 221 unique individuals. 86% completed one module, 9% complete 2 modules, and the remaining 5% completed between 3 and all 6 modules. There were statistically significant increases in knowledge in the epidemiology module.

6.
J Health Care Poor Underserved ; 30(3): 1053-1067, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31422988

RESUMO

The cost-effectiveness of hepatitis C virus (HCV) screening and treatment was examined in low-income, primarily Hispanic baby boomers born 1945-1965 using a Markov model of the natural history of HCV. The model was parameterized using costs and diagnostic data from 2008-2016 and from literature on disease progression and effectiveness of screening and treatment using direct acting anti-viral (DAA) therapy. The incremental cost-effectiveness ratio (ICER) was computed from the perspective of Medicare as payer, calculated over 20 years, and discounted at 3% per year. In the base case, HCV screening cost $3,334 versus $3,797 for no screening, and yielded more quality-adjusted life years (QALYs; 14.08 vs 13.96, respectively). The ICER for screening was still less than $20,000 per additional QALY with drug costs up to $100,000. Among low-income Hispanics, HCV screening was less costly for Medicare and more effective than no screening under most assumptions. This analysis supports investment in screening and treatment in Hispanics.


Assuntos
Antivirais/economia , Hepatite C/economia , Programas de Rastreamento/economia , Medicare/economia , Idoso , Antivirais/uso terapêutico , Análise Custo-Benefício , Hepatite C/diagnóstico , Hepatite C/tratamento farmacológico , Hepatite C/etnologia , Hispânico ou Latino/estatística & dados numéricos , Humanos , Pessoa de Meia-Idade , Pobreza/etnologia , Anos de Vida Ajustados por Qualidade de Vida , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...